Molecular characterization of macrolide resistance determinants [erm (B) and mef (A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF)

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 3, 2009, Pages 501-506

  Tazumi, Akihiro ^a,b   Maeda, Yasunori ^a,c   Goldsmith, Colin E ^a   Coulter, Wilson A ^d   Mason, Charlene ^d   Millar, B Cherie ^a   Mccalmont, Mark ^a   Rendall, Jackie ^a   Elborn, J Stuart ^a,e   Matsuda, Motoo ^b   Moore, John E ^a,c  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b AZABU UNIVERSITY   (Japan)

^c UNIVERSITY OF ULSTER   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Antibiotic resistance; Azithromycin; Commensal; Erythromycin

Indexed keywords

AZITHROMYCIN; BACTERIAL PROTEIN; ERYTHROMYCIN; MACROLIDE; PROTEIN ERM A; PROTEIN ERM B; PROTEIN ERM E; UNCLASSIFIED DRUG;

ALPHA HEMOLYTIC STREPTOCOCCUS; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA SEQUENCE; GENE MUTATION; GENOTYPE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPUTUM; STREPTOCOCCUS; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS AUSTALIS; STREPTOCOCCUS CRISTATUS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS INFANTIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PARASANGUINIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS SANGUINIS;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL PROTEINS; CYSTIC FIBROSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MACROLIDES; MEMBRANE PROTEINS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 69049089873     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp213     Document Type: Article

References (17)

1. Anon. About Cystic Fibrosis: What is CF? 2003. http://www.cff.org (15 May 2009, date last accessed).
2. Rajan S, Saiman L. Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 2002; 17: 47-56.
3. McArdle JR, Talwalkar JS. Macrolides in cystic fibrosis. Clin Chest Med 2007; 28: 347-60.
4. Giamarellos-Bourboulis EJ. Macrolides beyond the conventional antimicrobials: A class of potent immunomodulators. Int J Antimicrob Agents 2008; 31: 12-20.
5. Bell SC, Senini SL, McCormack JG. Macrolides in cystic fibrosis. Chron Respir Dis 2005; 2: 85-98.
6. McCormack J, Bell S, Senini S et al. Daily versus weekly azithromycin in cystic fibrosis patients. Eur Respir J 2007; 30 487-95.
7. Phaff SJ, Tiddens HA, Verbrugh HA et al. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis. J Antimicrob Chemother 2006; 57: 741-6.
8. Sibley CD, Parkins MD, Rabin HR et al. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci USA 2008; 105: 15070-5.
9. Täpp J, Thollesson M, Herrmann B. Phylogenetic relationships and genotyping of the genus Streptococcus by sequence determination of the RNase P RNA gene, rnpB. Int J Syst Evol Microbiol 2003; 53 1861-71.
10. Chen CC, Teng LJ, Chang TC. Identification of clinically relevant viridans group streptococci by sequence analysis of the 16S-23S ribosomal DNA spacer region. J Clin Microbiol 2004; 42: 2651-7.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
12. Millar BC, Xu J, Moore JE. Risk assessment models and contamination management: Implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology. J Clin Microbiol 2002; 40: 1575-80.
13. Amezaga MR, Carter PE, Cash P et al. Molecular epidemiology of erythromycin resistance in Streptococcus pneumoniae isolates from blood and noninvasive sites. J Clin Microbiol 2002; 40: 3313-8.
14. Ergin A, Ercis S, Hasc,elik G. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures. J Antimicrob Chemother 2006; 57: 139-41.
15. Artiles CF, Horcajada HI, Alamo AI et al. Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci. Rev Esp Quimioter 2007; 20: 317-22.
16. Arpin C, Canron MH, Maugein J et al. Incidence of mefA and mefE genes in viridans group streptococci. Antimicrob Agents Chemother 1999; 43: 2335-6.
17. Uh Y, Shin DH, Jang IH et al. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea. J Antimicrob Chemother 2004; 53 1095-7.